4:08 PM ET
10-Q
Financial Results
Adaptin Bio Q3 2026 Results: Net Loss of $957K, Loss Narrows
Adaptin Bio, Inc. reported a net loss of $3.31 million for the nine months ended September 30, 2026, compared to a $3.80 million loss in the prior year period. The company remains in the development stage with no revenue, maintaining a stockholders' deficit of $1.67 million and a cash balance of $430,333 as of the reporting date.
- Key figure
- Net loss $957K